
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>A Comprehensive Analysis of Renal and Endothelium Dysfunction Markers Fourteen Years after Hemorrhagic Fever with Renal Syndrome Contraction - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500005172119FFCA9.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="life" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC11122023/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11122023/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Life" /><meta name="citation_title" content="A Comprehensive Analysis of Renal and Endothelium Dysfunction Markers Fourteen Years after Hemorrhagic Fever with Renal Syndrome Contraction" /><meta name="citation_author" content="Dragan Ledina" /><meta name="citation_author_institution" content="Department of Infectious Diseases, Split University Hospital, 21000 Split, Croatia; moc.oohay@anidel.nagard (D.L.); moc.tsogodar@ovi (I.I.)" /><meta name="citation_author_institution" content="School of Medicine, University of Split, 21000 Split, Croatia" /><meta name="citation_author" content="Ivo Ivi&#x00107;" /><meta name="citation_author_institution" content="Department of Infectious Diseases, Split University Hospital, 21000 Split, Croatia; moc.oohay@anidel.nagard (D.L.); moc.tsogodar@ovi (I.I.)" /><meta name="citation_author_institution" content="School of Medicine, University of Split, 21000 Split, Croatia" /><meta name="citation_author" content="Ante Tadin" /><meta name="citation_author_institution" content="Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; moc.oohay@nidat.etna (A.T.); rh.mfb@ciludobk (K.B.)" /><meta name="citation_author" content="Kristian Boduli&#x00107;" /><meta name="citation_author_institution" content="Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; moc.oohay@nidat.etna (A.T.); rh.mfb@ciludobk (K.B.)" /><meta name="citation_author" content="James W. LeDuc" /><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA; ude.bmtu@cudelwj" /><meta name="citation_author" content="Alemka Markoti&#x00107;" /><meta name="citation_author_institution" content="Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; moc.oohay@nidat.etna (A.T.); rh.mfb@ciludobk (K.B.)" /><meta name="citation_author_institution" content="School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia" /><meta name="citation_author_institution" content="Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia" /><meta name="citation_publication_date" content="2024/05" /><meta name="citation_issue" content="5" /><meta name="citation_volume" content="14" /><meta name="citation_doi" content="10.3390/life14050575" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC11122023/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC11122023/" /><meta name="citation_pmid" content="38792596" /><meta name="DC.Title" content="A Comprehensive Analysis of Renal and Endothelium Dysfunction Markers Fourteen Years after Hemorrhagic Fever with Renal Syndrome Contraction" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Multidisciplinary Digital Publishing Institute  (MDPI)" /><meta name="DC.Contributor" content="Dragan Ledina" /><meta name="DC.Contributor" content="Ivo Ivi&#x00107;" /><meta name="DC.Contributor" content="Ante Tadin" /><meta name="DC.Contributor" content="Kristian Boduli&#x00107;" /><meta name="DC.Contributor" content="James W. LeDuc" /><meta name="DC.Contributor" content="Alemka Markoti&#x00107;" /><meta name="DC.Date" content="2024 May" /><meta name="DC.Identifier" content="10.3390/life14050575" /><meta name="DC.Language" content="en" /><meta property="og:title" content="A Comprehensive Analysis of Renal and Endothelium Dysfunction Markers Fourteen Years after Hemorrhagic Fever with Renal Syndrome Contraction" /><meta property="og:type" content="article" /><meta property="og:description" content="While the pathology of acute hemorrhagic fever with renal syndrome (HFRS) has been widely researched, details on the chronic HFRS sequelae remain mainly unexplored. In this study, we analyzed the clinical and laboratory characteristics of 30 convalescent ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11122023/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11122023/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Life%20(Basel)%22[journal]" class="navlink">Life (Basel)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11122023
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11122023/pdf/life-14-00575.pdf" class="int-view">PDF (222K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11122023/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11122023/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11122023" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11122023%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="XoXTVVCKyT49IAOdNBBpbyD1rc8kaL4kEx1F2v13UlQMRjAnkuQOiCPSPewEOfyn">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11122023%2F&amp;text=A%20Comprehensive%20Analysis%20of%20Renal%20and%20Endothelium%20Dysfunction%20Markers%20Fourteen%20Years%20after%20Hemorrhagic%20Fever%20with%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11122023%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11122023/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11122023/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38792596/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11122023/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38792596/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11122023/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11122023/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Life%20(Basel)%22[journal]" class="navlink">Life (Basel)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11122023
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-life.png" alt="Logo of life" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.mdpi.com/journal/life" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Life (Basel).</span> 2024 May; 14(5): 575. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Apr 30. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3390%2Flife14050575" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3390/life14050575</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC11122023</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38792596">38792596</a></div></div></div><h1 class="content-title">A Comprehensive Analysis of Renal and Endothelium Dysfunction Markers Fourteen Years after Hemorrhagic Fever with Renal Syndrome Contraction</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ledina%20D%5BAuthor%5D" class="affpopup" co-rid="_co_idm140081546063168" co-class="co-affbox">Dragan Ledina</a>, <span class="fm-role">Methodology</span>, <span class="fm-role">Formal analysis</span>, <span class="fm-role">Data curation</span>, <span class="fm-role">Writing &#x02013; original draft</span>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ivi&#x00107;%20I%5BAuthor%5D" class="affpopup" co-rid="_co_idm140081549020832" co-class="co-affbox">Ivo Ivi&#x00107;</a>, <span class="fm-role">Methodology</span>, <span class="fm-role">Formal analysis</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tadin%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140081552475456" co-class="co-affbox">Ante Tadin</a>, <span class="fm-role">Methodology</span>, <span class="fm-role">Investigation</span>,<sup>3,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Boduli&#x00107;%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140081540859184" co-class="co-affbox">Kristian Boduli&#x00107;</a>, <span class="fm-role">Formal analysis</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=LeDuc%20JW%5BAuthor%5D" class="affpopup" co-rid="_co_idm140081540854032" co-class="co-affbox">James W. LeDuc</a>, <span class="fm-role">Methodology</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup>4</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Markoti&#x00107;%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140081538722576" co-class="co-affbox">Alemka Markoti&#x00107;</a>, <span class="fm-role">Methodology</span>, <span class="fm-role">Formal analysis</span>, <span class="fm-role">Investigation</span>, <span class="fm-role">Resources</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>, <span class="fm-role">Supervision</span>, <span class="fm-role">Funding acquisition</span><sup>3,</sup><sup>5,</sup><sup>6,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140081546063168"><h3 class="no_margin">Dragan Ledina</h3><p><sup>1</sup>Department of Infectious Diseases, Split University Hospital, 21000 Split, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@anidel.nagard" class="oemail">moc.oohay@anidel.nagard</a> (D.L.); <a href="mailto:dev@null" data-email="moc.tsogodar@ovi" class="oemail">moc.tsogodar@ovi</a> (I.I.)</p><p><sup>2</sup>School of Medicine, University of Split, 21000 Split, Croatia</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ledina%20D%5BAuthor%5D">Dragan Ledina</a></div></div><div id="_co_idm140081549020832"><h3 class="no_margin">Ivo Ivi&#x00107;</h3><p><sup>1</sup>Department of Infectious Diseases, Split University Hospital, 21000 Split, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@anidel.nagard" class="oemail">moc.oohay@anidel.nagard</a> (D.L.); <a href="mailto:dev@null" data-email="moc.tsogodar@ovi" class="oemail">moc.tsogodar@ovi</a> (I.I.)</p><p><sup>2</sup>School of Medicine, University of Split, 21000 Split, Croatia</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ivi&#x00107;%20I%5BAuthor%5D">Ivo Ivi&#x00107;</a></div></div><div id="_co_idm140081552475456"><h3 class="no_margin">Ante Tadin</h3><p><sup>3</sup>Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@nidat.etna" class="oemail">moc.oohay@nidat.etna</a> (A.T.); <a href="mailto:dev@null" data-email="rh.mfb@ciludobk" class="oemail">rh.mfb@ciludobk</a> (K.B.)</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tadin%20A%5BAuthor%5D">Ante Tadin</a></div></div><div id="_co_idm140081540859184"><h3 class="no_margin">Kristian Boduli&#x00107;</h3><p><sup>3</sup>Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@nidat.etna" class="oemail">moc.oohay@nidat.etna</a> (A.T.); <a href="mailto:dev@null" data-email="rh.mfb@ciludobk" class="oemail">rh.mfb@ciludobk</a> (K.B.)</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Boduli&#x00107;%20K%5BAuthor%5D">Kristian Boduli&#x00107;</a></div></div><div id="_co_idm140081540854032"><h3 class="no_margin">James W. LeDuc</h3><p><sup>4</sup>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA; <a href="mailto:dev@null" data-email="ude.bmtu@cudelwj" class="oemail">ude.bmtu@cudelwj</a></p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=LeDuc%20JW%5BAuthor%5D">James W. LeDuc</a></div></div><div id="_co_idm140081538722576"><h3 class="no_margin">Alemka Markoti&#x00107;</h3><p><sup>3</sup>Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@nidat.etna" class="oemail">moc.oohay@nidat.etna</a> (A.T.); <a href="mailto:dev@null" data-email="rh.mfb@ciludobk" class="oemail">rh.mfb@ciludobk</a> (K.B.)</p><p><sup>5</sup>School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia</p><p><sup>6</sup>Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Markoti&#x00107;%20A%5BAuthor%5D">Alemka Markoti&#x00107;</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Panagiotis Georgianos, <span class="fm-role">Academic Editor</span></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140081551941104_ai idm140081546063296_ai idm140081548285536_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140081551941104_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140081551941104_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140081551941104_ai" style="display:none"><div class="fm-affl" id="af1-life-14-00575"><sup>1</sup>Department of Infectious Diseases, Split University Hospital, 21000 Split, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@anidel.nagard" class="oemail">moc.oohay@anidel.nagard</a> (D.L.); <a href="mailto:dev@null" data-email="moc.tsogodar@ovi" class="oemail">moc.tsogodar@ovi</a> (I.I.)</div><div class="fm-affl" id="af2-life-14-00575"><sup>2</sup>School of Medicine, University of Split, 21000 Split, Croatia</div><div class="fm-affl" id="af3-life-14-00575"><sup>3</sup>Research Department, University Hospital for Infectious Diseases &#x0201c;Dr. Fran Mihaljevi&#x00107;&#x0201d;, 10000 Zagreb, Croatia; <a href="mailto:dev@null" data-email="moc.oohay@nidat.etna" class="oemail">moc.oohay@nidat.etna</a> (A.T.); <a href="mailto:dev@null" data-email="rh.mfb@ciludobk" class="oemail">rh.mfb@ciludobk</a> (K.B.)</div><div class="fm-affl" id="af4-life-14-00575"><sup>4</sup>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA; <a href="mailto:dev@null" data-email="ude.bmtu@cudelwj" class="oemail">ude.bmtu@cudelwj</a></div><div class="fm-affl" id="af5-life-14-00575"><sup>5</sup>School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia</div><div class="fm-affl" id="af6-life-14-00575"><sup>6</sup>Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia</div><div id="c1-life-14-00575"><sup>*</sup>Correspondence: <a href="mailto:dev@null" data-email="rh.mfb@citokram.akmela" class="oemail">rh.mfb@citokram.akmela</a></div><div id="fn1-life-14-00575"><sup>&#x02020;</sup>Author&#x02019;s affiliation corresponds to the time of manuscript writing.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140081551941104_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2024 Apr 4; Revised 2024 Apr 21; Accepted 2024 Apr 26.</div></div><div class="permissions half_rhythm hide" id="idm140081551941104_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2024 by the authors.</div><div class="license half_rhythm">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://creativecommons.org/licenses/by/4.0/</a>).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-length="88" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>The data presented in this study are available on request from the corresponding author.</p></dd></dl></div><div id="abstract-a.i.b.u" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.i.b.utitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">While the pathology of acute hemorrhagic fever with renal syndrome (HFRS) has been widely researched, details on the chronic HFRS sequelae remain mainly unexplored. In this study, we analyzed the clinical and laboratory characteristics of 30 convalescent HFRS patients 14 years after the disease contraction, mainly emphasizing several endothelial dysfunction parameters. Convalescent HFRS patients exhibited significantly higher serum levels of erythrocyte sedimentation rate, von Willebrand factor, uric acid, C-reactive protein and immunoglobulin A when compared to healthy individuals. Furthermore, 24 h urine analyses revealed significantly lower sodium and potassium urine levels, as well as significantly higher proteinuria, microalbumin levels and &#x003b2;2-microglobulin levels when compared to healthy individuals. First morning urine analysis revealed significantly higher levels of hematuria in convalescent HFRS patients. None of the additional analyzed endothelium dysfunction markers were significantly different in post-HFRS patients and healthy individuals, including serum and urine P-selectin, E-selectin, soluble intercellular adhesion molecule 1, vascular intercellular adhesion molecule 1 (sVCAM-1) and vascular endothelial growth factor (VEGF). However, binary logistic regression revealed a weak association of serum sVCAM-1 and urine VEGF levels with HFRS contraction. Generally, our findings suggest mild chronic inflammation and renal dysfunction levels in convalescent HFRS patients 14 years after the disease contraction.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">HFRS, Puumala virus, Dobrava virus, renal dysfunction, endothelial dysfunction</span></div></div><div id="sec1-life-14-00575" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1-life-14-00575title">1. Introduction</h2><p class="p p-first">Hemorrhagic fever with renal syndrome (HFRS) is a zoonotic disease caused by the <em>Orthohantavirus</em> genus (hantaviruses, HTV). Two pathogenic HTVs, Puumala virus (PUUV) and Dobrava virus (DOBV), are the main causative agents of HFRS in Europe [<a href="#B1-life-14-00575" rid="B1-life-14-00575" class=" bibr popnode">1</a>,<a href="#B2-life-14-00575" rid="B2-life-14-00575" class=" bibr popnode">2</a>,<a href="#B3-life-14-00575" rid="B3-life-14-00575" class=" bibr popnode">3</a>,<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>]. The virology, epidemiology and clinical features of acute HFRS are well documented, but little is known about the chronic sequelae of HFRS and the accompanying immunopathogenesis. Acute HFRS patients usually exhibit various symptoms, including fever, strong headache, myalgia, back pain and nausea. However, severe cases can result in manifestations such as blurred vision, pneumonitis and bleeding [<a href="#B1-life-14-00575" rid="B1-life-14-00575" class=" bibr popnode">1</a>,<a href="#B2-life-14-00575" rid="B2-life-14-00575" class=" bibr popnode">2</a>,<a href="#B3-life-14-00575" rid="B3-life-14-00575" class=" bibr popnode">3</a>,<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>]. These symptoms can be followed by different degrees of renal involvement, possibly manifesting in oliguria, hematuria and proteinuria [<a href="#B1-life-14-00575" rid="B1-life-14-00575" class=" bibr popnode">1</a>,<a href="#B2-life-14-00575" rid="B2-life-14-00575" class=" bibr popnode">2</a>,<a href="#B3-life-14-00575" rid="B3-life-14-00575" class=" bibr popnode">3</a>,<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>]. The disease course is usually accompanied by pathological laboratory findings, including leukopenia and thrombocytopenia, as well as C-reactive protein (CRP), urea, creatinine and liver transaminase elevation [<a href="#B3-life-14-00575" rid="B3-life-14-00575" class=" bibr popnode">3</a>,<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>].</p><p>Endothelial cells (ECs), monocytes and macrophages represent the main target cells of HTV. The main pathophysiological changes in infected ECs include increased vascular permeability accompanied by endothelial activation, increased expression of adhesion molecules and recruitment of inflammatory cells in the involved organs. In HFRS pathology, vascular cells are both a target of cytokines and chemokines, as well as a source of their production [<a href="#B7-life-14-00575" rid="B7-life-14-00575" class=" bibr popnode">7</a>,<a href="#B8-life-14-00575" rid="B8-life-14-00575" class=" bibr popnode">8</a>]. The majority of pathophysiological changes during HFRS occur in the kidneys. As such, renal endothelium dysfunction (ED) plays a key role in the development and maintenance of HFRS-associated renal vascular permeability [<a href="#B3-life-14-00575" rid="B3-life-14-00575" class=" bibr popnode">3</a>,<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>,<a href="#B9-life-14-00575" rid="B9-life-14-00575" class=" bibr popnode">9</a>,<a href="#B10-life-14-00575" rid="B10-life-14-00575" class=" bibr popnode">10</a>]. Several studies demonstrated a negative association between glomerular filtration rate (GFR) and renal inflammatory activity during HFRS [<a href="#B11-life-14-00575" rid="B11-life-14-00575" class=" bibr popnode">11</a>,<a href="#B12-life-14-00575" rid="B12-life-14-00575" class=" bibr popnode">12</a>]. Moreover, evidence suggests a significant elevation of several acute kidney injury (AKI) markers in HFRS patients [<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B9-life-14-00575" rid="B9-life-14-00575" class=" bibr popnode">9</a>,<a href="#B13-life-14-00575" rid="B13-life-14-00575" class=" bibr popnode">13</a>]. Endothelial damage in patients with AKI during HFRS results in elevated markers of ED [<a href="#B7-life-14-00575" rid="B7-life-14-00575" class=" bibr popnode">7</a>,<a href="#B8-life-14-00575" rid="B8-life-14-00575" class=" bibr popnode">8</a>]. Typically, ED detection is based on measuring the levels of circulating markers of endothelial function such as endothelin-1, tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI) and vascular endothelial growth factor (VEGF). Additionally, ED detection can be established by measuring the levels of adhesion molecules, such as soluble intercellular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1 (sVCAM-1), P-selectin and E-selectin [<a href="#B14-life-14-00575" rid="B14-life-14-00575" class=" bibr popnode">14</a>,<a href="#B15-life-14-00575" rid="B15-life-14-00575" class=" bibr popnode">15</a>,<a href="#B16-life-14-00575" rid="B16-life-14-00575" class=" bibr popnode">16</a>]. Notably, several studies found increased levels of VEGF in the sera and urine of HFRS patients [<a href="#B17-life-14-00575" rid="B17-life-14-00575" class=" bibr popnode">17</a>]. Similarly, recent evidence suggests increased levels of endothelin-1, tPA, PAI, sICAM-1, sVCAM-1 and selectins in the sera of HFRS patients [<a href="#B13-life-14-00575" rid="B13-life-14-00575" class=" bibr popnode">13</a>,<a href="#B18-life-14-00575" rid="B18-life-14-00575" class=" bibr popnode">18</a>,<a href="#B19-life-14-00575" rid="B19-life-14-00575" class=" bibr popnode">19</a>,<a href="#B20-life-14-00575" rid="B20-life-14-00575" class=" bibr popnode">20</a>]. However, data on urine levels of endothelin-1, sICAM-1, sVCAM-1 and selectins during HFRS are still lacking, with only one study suggesting non-pathological levels of endothelin-1 in Croatian HFRS patients [<a href="#B13-life-14-00575" rid="B13-life-14-00575" class=" bibr popnode">13</a>].</p><p class="p p-last">While the pathology of HFRS has been extensively researched, little is known about chronic HFRS sequelae. So far, very few follow-up studies related to chronic HFRS after PUUV or DOBV infection have been published. Three of the stated studies suggested tubulointerstitial changes, persistently lower levels of GFR and higher levels of proteinuria, hematuria and other AKI markers three, six and ten years after acute HFRS [<a href="#B21-life-14-00575" rid="B21-life-14-00575" class=" bibr popnode">21</a>,<a href="#B22-life-14-00575" rid="B22-life-14-00575" class=" bibr popnode">22</a>,<a href="#B23-life-14-00575" rid="B23-life-14-00575" class=" bibr popnode">23</a>]. Similarly, a study conducted by Dudarev et al. emphasized the importance of glomerular and tubular dysfunction in convalescent HFRS [<a href="#B24-life-14-00575" rid="B24-life-14-00575" class=" bibr popnode">24</a>]. On the contrary, a recent study reported physiologically normal GFR values in HFRS patients ten years after PUUV or DOBV infection [<a href="#B11-life-14-00575" rid="B11-life-14-00575" class=" bibr popnode">11</a>]. Notably, none of the stated research studied HFRS sequelae in the context of renal ED. In this study, we investigate the existence and severity of chronic renal sequelae, as well as their association with ED markers 14 years after HFRS contraction in patients infected with PUUV or DOBV during an HFRS outbreak in Croatia.</p></div><div id="sec2-life-14-00575" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2-life-14-00575title">2. Materials and Methods</h2><p class="p p-first">This study recruited 30 adult HFRS patients hospitalized in Split University Hospital (Croatia) during the HFRS epidemic in 1995. All patients were prospectively analyzed 14 years after PUUV or DOBV infection. Patient exclusion criteria included malignant disease, epilepsy, diabetes, cerebrovascular insult, myocardial infarction, permanent dialysis and treatment with angiotensin convertase inhibitors, Ca<sup>2+</sup> blockers or angiotensin II receptor antagonists. Similarly, 30 age- and sex-matched healthy individuals were analyzed during the corresponding time period. Exclusion criteria for the control group were as follows: chronic diseases (including chronic renal disease and hypertension) and treatment with angiotensin convertase inhibitors, Ca<sup>2+</sup> blockers or angiotensin II receptor antagonists. Both the patient and control groups were tested for PUUV and DUBV infection with ELISA tests for specific immunoglobulin G (IgG) antibodies. All participants signed an informed consent form. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the School of Medicine, University of Zagreb.</p><p>Complete anamnesis was taken for all of the analyzed patients. All participants underwent a complete physical examination. Three blood pressure measurements in the seated position within time intervals of 30 min were taken and subsequently averaged for data analysis. This included systolic pressure, diastolic pressure and mean arterial pressure calculated with the following formula: 1/3 * (systolic pressure&#x02014;diastolic pressure) + diastolic pressure. Abdominal and liver ultrasounds were performed on all participants (Toshiba &#x0201c;Nemio&#x0201d; SSA-550 A, Tokyo, Japan). Participants&#x02019; sera were collected after physical examination. Standard hematological parameters were measured on a hematology analyzer (Advia 120 Hematology System Bayer Corporation, Tarrytown, New York, NY, USA) and included erythrocyte sedimentation rate (ESR), erythrocyte count, hemoglobin, leukocyte count and platelet count. Furthermore, von Willebrand factor (vWF) and D-dimers were measured on a suitable analyzer (Behring Coagulation Timer, Version 1.7, Dade Behring Gmbh, Marburg, Germany). The biochemical analysis included the assessment of aspartate aminotransferase (AST), urea, uric acid, triiodothyronine (T3), thyroxin (T4), CRP and immunoglobulin A (IgA) levels. Regarding urine analysis, three consecutive samples of 24 h urine were collected following a three-day NaCl-restricted diet (&#x02264;6 g/day). The measured values were averaged across the three collected urine samples for data analysis. This analysis encompassed electrolyte (sodium, potassium, chloride), urea, urine protein, microalbumin and &#x003b2;2-microglobulin level determination (Olympus AU 2700, Olympus Mishima Co., Ltd., Shizuoka, Japan). Additionally, GFR was calculated using Lavy&#x02019;s formula. The first morning urine samples were cultured and analyzed for nitrites, urine proteins, erythrocytes and leukocytes. Specific ED markers were measured in serum and urine samples, including P-selectin, E-selectin, sICAM-1, sVCAM-1 and VEGF, using ELISA tests (Quantikine, R&#x00026;D System, Oxford, UK).</p><p class="p p-last">Quantitative variables are expressed as medians and ranges, while qualitative variables are given as absolute values and percentages. Distribution normality was assessed graphically and with the Shapiro&#x02013;Wilk test. Quantitative variables with nonparametric distributions were compared using the Mann&#x02013;Whitney test. Association between categorical variables was assessed using the chi-square or Fisher&#x02019;s exact test, as appropriate. The relationship between numeric variables was assessed using Spearman&#x02019;s correlation coefficient and the correlation test. Binary logistic regression was utilized to classify participants into post-HFRS patients and healthy individuals, with predictor sets chosen using the forward selection algorithm. The model was evaluated on the training dataset using specificity and selectivity measures. All tests were two-tailed with the significance factor set to 95%. Statistical analyses were performed using R (version 4.1.2.) [<a href="#B25-life-14-00575" rid="B25-life-14-00575" class=" bibr popnode">25</a>].</p></div><div id="sec3-life-14-00575" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3-life-14-00575title">3. Results</h2><div id="sec3dot1-life-14-00575" class="sec sec-first"><h3 id="sec3dot1-life-14-00575title">3.1. General Participant Characteristics</h3><p class="p p-first-last">This study recruited 30 post-HFRS patients and 30 age- and sex-matched healthy individuals. Participants&#x02019; demographic and clinical parameters are shown in <a href="/pmc/articles/PMC11122023/table/life-14-00575-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="life-14-00575-t001" rid-ob="ob-life-14-00575-t001" co-legend-rid=""><span>Table 1</span></a>. All patients were male with a median age of 41 years (range 31&#x02013;49 years) and a median body weight of 89 kg (range 61&#x02013;111 kg). Furthermore, 90% of patients were infected with PUUV, 6.7% of patients were infected with DOBV and the viral species of one patient was undetermined due to cross-reactivity. We did not observe a significant difference between the patients and the control group in terms of age or body weight (<em>p</em> &#x0003e; 0.05). The most common post-HFRS symptoms included headache (50.0%), depression (50.0%), painful lumbar succussion (36.7%), hepatomegaly (10,0%), frequent urination (6.7%) and splenomegaly (6.7%). When compared to healthy individuals, we found significantly higher systolic pressure (medians 130.0 and 123.3 mmHg, <em>p</em> = 0.025), diastolic pressure (medians 86.7 and 80 mmHg, <em>p</em> = 0.001) and mean arterial pressure (medians 101.1 and 91.6 mmHg, <em>p</em> &#x0003c; 0.001) levels in post-HFRS patients.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="life-14-00575-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Participants&#x02019; demographic and clinical parameters.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameters</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N (%)/Median (Range)</th></tr></thead><tbody><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Patients (N = 30)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male sex</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (100.0%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="middle" rowspan="1" colspan="1">41 (31&#x02013;49)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Body weight (kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">89 (61&#x02013;111)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Systolic pressure (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">130.0 (110.0&#x02013;160.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diastolic pressure (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">86.7 (60.0&#x02013;120.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mean arterial pressure (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">101.1 (78.2&#x02013;126.6)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Viral species</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PUUV</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (90.0%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">DOBV</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (6.7%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Undetermined</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (3.3%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Headache</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (50.0%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Depression</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (50.0%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Painful lumbar succussion</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (36.7%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hepatomegaly</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (10.0%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Frequent urination</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (6.7%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Splenomegaly</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (6.7%)</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Healthy individuals (N = 30)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male sex</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (100.0%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="middle" rowspan="1" colspan="1">38.8 (30&#x02013;49)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Body weight (kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">92 (73&#x02013;110)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Systolic pressure (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">123.3 (100.0&#x02013;150.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diastolic pressure (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">80.0 (60.0&#x02013;100.0)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean arterial pressure (mmHg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.6 (74.9&#x02013;116.5)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140081542385808"><a target="object" rel="noopener" href="/pmc/articles/PMC11122023/table/life-14-00575-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.a.e.a"><p class="p p-first-last">PUUV = Puumala virus; DOBV = Dobrava virus.</p></div></div></div></div><div id="sec3dot2-life-14-00575" class="sec"><h3 id="sec3dot2-life-14-00575title">3.2. Hematological and Biochemical Parameters in Post-HFRS Patients</h3><p class="p p-first-last">Firstly, we analyzed the potential differences in post-HFRS patients and healthy individuals in the selected hematological and biochemical parameters (<a href="/pmc/articles/PMC11122023/table/life-14-00575-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="life-14-00575-t002" rid-ob="ob-life-14-00575-t002" co-legend-rid=""><span>Table 2</span></a>). When compared to healthy individuals, post-HFRS patients exhibited significantly higher ESR (medians 6 and 4 mm/h, <em>p</em> = 0.025) and vWF levels (medians 1.24 and 1.04 IU/L, <em>p</em> = 0.008). On the other hand, we did not find a significant difference in post-HFRS patients and the control group in hemoglobin levels, D-dimer levels and erythrocyte, leukocyte or platelet count (<em>p</em> &#x0003e; 0.05). Furthermore, post-HFRS patients exhibited significantly increased levels of uric acid (medians 319 and 297 &#x000b5;mol/L, <em>p</em> = 0.025), CRP (medians 2.5 and 1.2 mg/L) and IgA (medians 2.3 and 1.8 g/L, <em>p</em> = 0.014), as well as decreased levels of T4 (medians 87 and 104 mmol/L, <em>p</em> = 0.005). We did not find a significant difference between the serum levels of AST, urea or T3 (<em>p</em> &#x0003e; 0.05). Notably, medians of all of the stated parameters were within the reference value range of the respective parameters for both the post-HFRS patient group and the control group.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="life-14-00575-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>Comparison of selected hematological and biochemical parameters in post-HFRS patients and healthy individuals.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Hematological</strong>
<br />
<strong>Parameters</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Reference Values</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Post-HFRS</strong>
<br />
<strong>Patients</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Healthy</strong>
<br />
<strong>Individuals</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong><em>p</em>-Value</strong>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ESR (mmh)</td><td align="center" valign="middle" rowspan="1" colspan="1">4&#x02013;24</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (1&#x02013;31)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (1&#x02013;12)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.025</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Erythrocytes (&#x000d7;10<sup>12</sup>/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.30&#x02013;5.72</td><td align="center" valign="middle" rowspan="1" colspan="1">4.8 (4.2&#x02013;6.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.1 (4.0&#x02013;5.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.340</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hemoglobin (g/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">138&#x02013;175</td><td align="center" valign="middle" rowspan="1" colspan="1">149 (130&#x02013;178)</td><td align="center" valign="middle" rowspan="1" colspan="1">153 (118&#x02013;171)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.599</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Leukocytes (&#x000d7;10<sup>9</sup>/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4&#x02013;9.7</td><td align="center" valign="middle" rowspan="1" colspan="1">6.8 (3.9&#x02013;12.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7 (4.1&#x02013;9.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.871</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Platelets (&#x000d7;10<sup>9</sup>/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">158&#x02013;424</td><td align="center" valign="middle" rowspan="1" colspan="1">231 (149&#x02013;492)</td><td align="center" valign="middle" rowspan="1" colspan="1">227 (169&#x02013;344)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.773</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vWF (IU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5&#x02013;1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (0.64&#x02013;1.80)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.04 (0.47&#x02013;1.60)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-dimers (mg/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2 (0.1&#x02013;0.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2 (0.1&#x02013;0.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.917</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Biochemical</strong>
<br />
<strong>Parameters</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Reference Values</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Post-HFRS</strong>
<br />
<strong>Patients</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Healthy</strong>
<br />
<strong>Individuals</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong><em>p</em>-Value</strong>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AST (U/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">1&#x02013;37</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (14&#x02013;59)</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (15&#x02013;45)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.445</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Urea (mmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6&#x02013;7.2</td><td align="center" valign="middle" rowspan="1" colspan="1">5.8 (2.4&#x02013;7.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1 (4.1&#x02013;8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.105</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Uric acid (&#x003bc;mol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">142&#x02013;416</td><td align="center" valign="middle" rowspan="1" colspan="1">319 (157&#x02013;556)</td><td align="center" valign="middle" rowspan="1" colspan="1">297 (213&#x02013;387)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.025</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T3 (mmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.26&#x02013;2.75</td><td align="center" valign="middle" rowspan="1" colspan="1">1.80 (1.18&#x02013;2.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.73 (0.95&#x02013;2.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.283</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T4 (mmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">58&#x02013;161</td><td align="center" valign="middle" rowspan="1" colspan="1">87 (75&#x02013;139)</td><td align="center" valign="middle" rowspan="1" colspan="1">104 (67&#x02013;130)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CRP (mg/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0&#x02013;5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 (0.5&#x02013;22.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 (0.5&#x02013;7.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgA (g/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7&#x02013;4.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3 (0.9&#x02013;6.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8 (0.9&#x02013;3.7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140081550096416"><a target="object" rel="noopener" href="/pmc/articles/PMC11122023/table/life-14-00575-t002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.b.e.a"><p class="p p-first-last">HFRS = hemorrhagic fever with renal syndrome; ESR = erythrocyte sedimentation rate; vWF = von Willebrand factor; AST = aspartate aminotransferase; T3 = triiodothyronine; T4 = thyroxin; CRP = C-reactive protein; IgA = immunoglobulin A.</p></div></div></div></div><div id="sec3dot3-life-14-00575" class="sec"><h3 id="sec3dot3-life-14-00575title">3.3. Urine Tests in Post-HFRS Patients</h3><p class="p p-first">In the following part of the study, we compared the results of 24 h urine tests in post-HFRS patients and healthy individuals (<a href="/pmc/articles/PMC11122023/table/life-14-00575-t003/" target="table" class="fig-table-link figpopup" rid-figpopup="life-14-00575-t003" rid-ob="ob-life-14-00575-t003" co-legend-rid=""><span>Table 3</span></a>). When compared to healthy individuals, post-HFRS patients exhibited significantly lower urine levels of sodium (medians 157 and 230 mmol/d, <em>p</em> = 0.040) and potassium (medians 62 and 65 mmol/d, <em>p</em> = 0.010). We also noticed lower levels of chlorides (medians 185 and 223 mmol/d), which were not statistically significant (<em>p</em> = 0.061). Several urine parameters were significantly higher in post-HFRS patients than in the control group. These parameters included urine proteins (medians 133 and 90 mg/d, <em>p</em> = 0.023), microalbumin (medians 6.9 and 5.3 mg/d, <em>p</em> = 0.011) and &#x003b2;2-microglobulin (medians 0.20 amd 0.10 mg/L, <em>p</em> = 0.027). Again, medians of all of the 24 h urine parameters were within the reference interval of the respective parameters for both the post-HFRS patient group and the control group.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="life-14-00575-t003"><h3>Table 3</h3><!--caption a7--><div class="caption"><p>Comparison of 24 h urine test results in post-HFRS patients and healthy individuals.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">24 h-Urine<br />Analysis</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference Values</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post-HFRS<br />Patients<br />Median (Range)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Healthy<br />Individuals<br />Median (Range)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><em>p</em>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sodium (mmol/d)</td><td align="center" valign="middle" rowspan="1" colspan="1">120&#x02013;250</td><td align="center" valign="middle" rowspan="1" colspan="1">157 (20&#x02013;503)</td><td align="center" valign="middle" rowspan="1" colspan="1">230 (107&#x02013;362)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.040</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Potassium (mmol/d)</td><td align="center" valign="middle" rowspan="1" colspan="1">50&#x02013;100</td><td align="center" valign="middle" rowspan="1" colspan="1">62 (34&#x02013;129)</td><td align="center" valign="middle" rowspan="1" colspan="1">65 (28&#x02013;94)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.010</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chloride (mmol/d)</td><td align="center" valign="middle" rowspan="1" colspan="1">128&#x02013;257</td><td align="center" valign="middle" rowspan="1" colspan="1">185 (32&#x02013;459)</td><td align="center" valign="middle" rowspan="1" colspan="1">223 (119&#x02013;407)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.061</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Urea (mmol/d)</td><td align="center" valign="middle" rowspan="1" colspan="1">250&#x02013;570</td><td align="center" valign="middle" rowspan="1" colspan="1">346 (180&#x02013;640)</td><td align="center" valign="middle" rowspan="1" colspan="1">445 (309&#x02013;776)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.112</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Proteins (mg/d)</td><td align="center" valign="middle" rowspan="1" colspan="1">25&#x02013;150</td><td align="center" valign="middle" rowspan="1" colspan="1">133 (51&#x02013;262)</td><td align="center" valign="middle" rowspan="1" colspan="1">90 (13&#x02013;157)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.023</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Microalbumin (mg/d)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.0&#x02013;30.0</td><td align="center" valign="middle" rowspan="1" colspan="1">6.9 (2.7&#x02013;131.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.3 (0.7&#x02013;8.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;2-microglobulin (mg/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00&#x02013;0.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.20 (0.08&#x02013;0.33)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10 (0.13&#x02013;23.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.027</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140081546181888"><a target="object" rel="noopener" href="/pmc/articles/PMC11122023/table/life-14-00575-t003/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.c.e.a"><p class="p p-first-last">HFRS = hemorrhagic fever with renal syndrome.</p></div></div></div><p class="p p-last">We also analyzed the first morning urines of post-HFRS patients and the control group (<a href="/pmc/articles/PMC11122023/table/life-14-00575-t004/" target="table" class="fig-table-link figpopup" rid-figpopup="life-14-00575-t004" rid-ob="ob-life-14-00575-t004" co-legend-rid=""><span>Table 4</span></a>). We did not record statistically significant differences in urine-positive nitrite, proteinuria or leukocyturia frequencies (<em>p</em> &#x0003e; 0.05). However, post-HFRS patients exhibited significantly higher frequencies of hematuria compared to healthy individuals (OR = 5.07, 95% CI 1.13&#x02013;31.12, <em>p</em> = 0.030). Furthermore, we did not find a significant difference in the GFR of post-HFRS patients and healthy individuals (medians 88.00 and 87.39 mL/min, <em>p</em> &#x0003e; 0.05). Finally, post-HFRS patients displayed significantly lower morning urine osmolality when compared to healthy individuals (medians 830 and 880 mOsm/kg H20, <em>p</em> = 0.011).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="life-14-00575-t004"><h3>Table 4</h3><!--caption a7--><div class="caption"><p>Comparison of first morning urine test results in post-HFRS patients and healthy individuals.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">First morning Urine<br />Analysis</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post-HFRS<br />Patients<br />N (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Healthy<br />Individuals<br />N (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><em>p</em>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Positive nitrites (&#x0003e;0 mmol/L) </td><td align="center" valign="middle" rowspan="1" colspan="1">1 3.6%</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.999</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Proteins &#x0003e; 0.2 mg/dL</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (23.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (6.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.146</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Erythrocytes &#x0003e; 2 per field of view</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (36.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (10.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.030</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leukocytes &#x0003e; 2 per field of view</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (56.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (33.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.119</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140081549829376"><a target="object" rel="noopener" href="/pmc/articles/PMC11122023/table/life-14-00575-t004/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.d.e.a"><p class="p p-first-last">HFRS = hemorrhagic fever with renal syndrome.</p></div></div></div></div><div id="sec3dot4-life-14-00575" class="sec"><h3 id="sec3dot4-life-14-00575title">3.4. Specific Endothelial Dysfunction Markers in Post-HFRS Patients</h3><p class="p p-first">Finally, we examined specific ED parameters in serum and 24 h urine samples of post-HFRS patients (<a href="/pmc/articles/PMC11122023/table/life-14-00575-t005/" target="table" class="fig-table-link figpopup" rid-figpopup="life-14-00575-t005" rid-ob="ob-life-14-00575-t005" co-legend-rid=""><span>Table 5</span></a>). While several serum ED markers exhibited higher values in post-HFRS patients than in healthy individuals, none of the differences were statistically significant (P-selectin: medians 101.4 and 84.0 ng/mL; E-selectin: medians 50.3 and 46.3 ng/mL; sICAM-1: medians 205.2 and 165.3 ng/mL; and VEGF: 278.5 and 236.0 pg/mL, <em>p</em> &#x0003e; 0.05). When considering urine ED markers, post-HFRS patients exhibited higher sVCAM-1 (medians 20.6 and 5.3 ng/mL) and VEGF (medians 276.1 and 242.2 pg/mL) levels. However, these differences were not statistically significant (<em>p</em> = 0.080 and <em>p</em> = 0.294, respectively). The urine levels of other specific ED markers were similar in the post-HFRS patient and control groups (P-selectin: medians 0.1 and 0.1 ng/mL; E-selectin: medians 0.2 and 0.2 ng/mL; and sICAM-1: medians 0.0 and 0.0 ng/mL, <em>p</em> &#x0003e; 0.05). </p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="life-14-00575-t005"><h3>Table 5</h3><!--caption a7--><div class="caption"><p>Comparison of specific endothelial dysfunction markers in post-HFRS patients and healthy individuals.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>ED Markers in Serum</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Post-HFRS</strong>
<br />
<strong>Patients</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Healthy</strong>
<br />
<strong>Individuals</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<strong><em>p</em>-Value</strong>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">P-selectin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">101.4 (45.6&#x02013;194.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">84.0 (24.2&#x02013;311.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.265</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E selectin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">50.3 (21.7&#x02013;121.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">46.3 (31.0&#x02013;103.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.505</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">sICAM-1 (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">205.2 (89.9&#x02013;566.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">165.3 (99.1&#x02013;430.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.203</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">sVCAM-1 (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">439.3 (284.6&#x02013;698.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">507.9 (301.9&#x02013;880.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.299</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VEGF (pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">278.5 (57.0&#x02013;824.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">236.0 (58.0&#x02013;960.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.921</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>ED Markers in Urine</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Post-HFRS</strong>
<br />
<strong>Patients</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Healthy</strong>
<br />
<strong>Individuals</strong>
<br />
<strong>Median (Range)</strong>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong><em>p</em>-Value</strong>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">P-selectin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 (0.0&#x02013;0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 (0.0&#x02013;1.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.382</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E selectin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 (0.0&#x02013;0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 (0.0&#x02013;0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.948</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">sICAM-1 (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0 (0.0&#x02013;1.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0 (0.0&#x02013;4.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.761</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">sVCAM-1 (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.6 (0.0&#x02013;97.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.3 (0.1&#x02013;100.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.080</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VEGF (pg/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">276.1 (1.1&#x02013;1847.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">242.2 (117.0&#x02013;778.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.294</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140081556840640"><a target="object" rel="noopener" href="/pmc/articles/PMC11122023/table/life-14-00575-t005/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.e.e.a"><p class="p p-first-last">ED = endothelial dysfunction; HFRS = hemorrhagic fever with renal syndrome; sICAM-1 = soluble intercellular adhesion molecule 1; sVCAM-1 = vascular intercellular adhesion molecule 1; VEGF = vascular endothelial growth factor.</p></div></div></div><p class="p p-last">We also evaluated the potential correlation of hematological, biochemical and 24 h urine parameters with specific serum and urine ED markers. We found a moderate positive correlation between urine microalbumin and serum sVCAM-1 levels (r = 0.45, <em>p</em> = 0.044) and between E-selectin and VEGF serum levels (r = 0.40, <em>p</em> = 0.030).</p></div><div id="sec3dot5-life-14-00575" class="sec sec-last"><h3 id="sec3dot5-life-14-00575title">3.5. Multivariate Analysis of Post-HFRS Patient Markers</h3><p class="p p-first-last">Finally, we assessed the potential of the analyzed laboratory markers in classifying post-HFRS patients and healthy individuals using binary logistic regression (<a href="/pmc/articles/PMC11122023/table/life-14-00575-t006/" target="table" class="fig-table-link figpopup" rid-figpopup="life-14-00575-t006" rid-ob="ob-life-14-00575-t006" co-legend-rid=""><span>Table 6</span></a>). Analyzed parameters with the best predictive ability for post-HFRS were serum CRP, 24 h urine microalbumin, serum sVCAM-1 and urine VEGF levels. Increasing the levels of serum CRP by one unit would increase the odds of a participant being in the post-HFRS patient group by 2.691 (<em>p</em> = 0.050). Furthermore, increasing the levels of 24 h urine microalbumin would increase the odds of a participant being in the post-HFRS patient group by 1.474 (<em>p</em> = 0.048). Finally, increasing the levels of urine VEGF by one unit would increase the odds of a participant being in the post-HFRS patient group by 1.015 (<em>p</em> = 0.041). The accuracy of the stated model on the training dataset was 91.1% (sensitivity: 93.1%; specificity: 88.9%).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="life-14-00575-t006"><h3>Table 6</h3><!--caption a7--><div class="caption"><p>Binary logistic regression model classifying post-HFRS patients and healthy individuals.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameter</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coefficient</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Odds Ratio</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><em>p</em>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">CRP</td><td align="center" valign="middle" rowspan="1" colspan="1">0.990</td><td align="center" valign="middle" rowspan="1" colspan="1">2.691</td><td align="center" valign="middle" rowspan="1" colspan="1">0.050</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24 h urine microalbumin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.338</td><td align="center" valign="middle" rowspan="1" colspan="1">1.474</td><td align="center" valign="middle" rowspan="1" colspan="1">0.048</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Serum sVCAM-1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0.974</td><td align="center" valign="middle" rowspan="1" colspan="1">0.043</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urine VEGF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.041</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140081543528640"><a target="object" rel="noopener" href="/pmc/articles/PMC11122023/table/life-14-00575-t006/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.l.f.e.a"><p class="p p-first-last">CRP = C-reactive protein; sVCAM-1 = vascular intercellular adhesion molecule 1; VEGF = vascular endothelial growth factor.</p></div></div></div></div></div><div id="sec4-life-14-00575" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4-life-14-00575title">4. Discussion</h2><p class="p p-first">This prospective study aimed to reduce the research gap in HFRS sequelae and the potential impact of HFRS on long-term patient health. The clinical course of acute HFRS is manifested by immunopathological events and ED, often leading to vascular leakage and hypertension [<a href="#B1-life-14-00575" rid="B1-life-14-00575" class=" bibr popnode">1</a>,<a href="#B2-life-14-00575" rid="B2-life-14-00575" class=" bibr popnode">2</a>,<a href="#B3-life-14-00575" rid="B3-life-14-00575" class=" bibr popnode">3</a>,<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>]. One of the main consequences of renal ED and local inflammation during acute HFRS is AKI, possibly resulting in manifestations such as lower GFR, proteinuria, leukocyturia, hematuria and, in severe cases, renal failure [<a href="#B4-life-14-00575" rid="B4-life-14-00575" class=" bibr popnode">4</a>,<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B6-life-14-00575" rid="B6-life-14-00575" class=" bibr popnode">6</a>,<a href="#B9-life-14-00575" rid="B9-life-14-00575" class=" bibr popnode">9</a>]. On the other hand, the dynamics of chronic changes following acute HFRS are partially known. Endothelium impairment in acute HFRS could, in some patients, potentially induce chronic changes in microcirculation, leading to post-HFRS events such as hypertension, permanent damage of small blood vessels in glomeruli and the development of microalbuminuria [<a href="#B10-life-14-00575" rid="B10-life-14-00575" class=" bibr popnode">10</a>,<a href="#B11-life-14-00575" rid="B11-life-14-00575" class=" bibr popnode">11</a>].</p><p>In this study, we performed detailed hematological, biochemical and urine analyses in post-HFRS patients 14 years after HFRS contraction. To our knowledge, this represents the longest time period of HFRS patients monitoring in the published research [<a href="#B11-life-14-00575" rid="B11-life-14-00575" class=" bibr popnode">11</a>,<a href="#B21-life-14-00575" rid="B21-life-14-00575" class=" bibr popnode">21</a>,<a href="#B22-life-14-00575" rid="B22-life-14-00575" class=" bibr popnode">22</a>,<a href="#B23-life-14-00575" rid="B23-life-14-00575" class=" bibr popnode">23</a>,<a href="#B24-life-14-00575" rid="B24-life-14-00575" class=" bibr popnode">24</a>]. Our results reveal significant changes in several markers of chronic inflammation and renal dysfunction. Several studies reported significantly higher values of ERS and serum CRP levels during acute HFRS, as well as their correlation with HFRS-related systemic and local inflammation [<a href="#B5-life-14-00575" rid="B5-life-14-00575" class=" bibr popnode">5</a>,<a href="#B26-life-14-00575" rid="B26-life-14-00575" class=" bibr popnode">26</a>]. In this context, the slightly elevated ESR and CRP levels found in our study could indicate chronic inflammatory processes in post-HFRS patients. This represents an important result considering that inflammatory markers have not been extensively studied in HFRS sequelae. Importantly, our results also indicate significantly higher levels of vWF in post-HRFS patients, possibly pointing toward chronic ED. When considering other hematological parameters, we did not observe a significant difference in erythrocyte count or hemoglobin levels between post-HFRS patients and healthy individuals. While anemia represents a common laboratory finding during acute HFRS [<a href="#B27-life-14-00575" rid="B27-life-14-00575" class=" bibr popnode">27</a>], our findings indicate normal erythrocyte levels in post-HFRS patients. Interestingly, the post-HFRS patients analyzed in this study exhibited significantly higher levels of serum uric acid, possibly resulting from lower renal function or hypertension. This finding agrees with the results of a study conducted by Dodarev et al., hypothesizing glomerular and tubular dysfunction in post-HFRS patients as a result of glomerular hypertension and tubular damage [<a href="#B24-life-14-00575" rid="B24-life-14-00575" class=" bibr popnode">24</a>]. The finding of lower T4 levels in post-HFRS patients could be a result of chronic inflammation and leukocytosis, agreeing with trends commonly observed in acute HFRS [<a href="#B28-life-14-00575" rid="B28-life-14-00575" class=" bibr popnode">28</a>]. When considering liver function, the levels of AST were not significantly different in post-HFRS patients, with a relatively low percentage of patients exhibiting hepatomegaly or other ultrasound abnormalities. All in all, hematological and biochemical analyses conducted in our study could point towards relatively mild levels of chronic inflammation in convalescent HFRS. </p><p>The results of 24 h urine tests in post-HFRS patients revealed significantly lower levels of sodium and potassium, as well as significantly higher levels of urine proteins, microalbumin and &#x003b2;2-microglobulin. The lower levels of urine electrolytes observed in the studied patients could suggest a lower tubular reabsorption capacity, agreeing with the results of a similar study on post-HFRS patients [<a href="#B24-life-14-00575" rid="B24-life-14-00575" class=" bibr popnode">24</a>]. Our results also demonstrate significantly higher proteinuria and microalbuminuria levels when analyzing 24 h urines of post-HFRS patients, as well as a higher frequency of proteinuria in the morning urine of post-HFRS patients, which was not statistically significant. The presented findings agree with the results of similar studies on convalescent HFRS [<a href="#B11-life-14-00575" rid="B11-life-14-00575" class=" bibr popnode">11</a>,<a href="#B22-life-14-00575" rid="B22-life-14-00575" class=" bibr popnode">22</a>,<a href="#B23-life-14-00575" rid="B23-life-14-00575" class=" bibr popnode">23</a>] and contextualize proteinuria as an important renal dysfunction marker persisting for 14 years after acute HFRS. While the pathological mechanism of mild proteinuria in convalescent HFRS is not known, this finding points towards glomerular filtration disturbance possibly caused by hypertension and renal vasculature damage. Our results also reveal significantly higher 24 h urine &#x003b2;2-microglobulin levels and a positive correlation between serum CRP levels, proteinuria and &#x003b2;2-microglobulin. These results are in line with the observations of other studies on HFRS sequelae and may suggest post-HFRS renal tubule damage as a consequence of local chronic inflammation [<a href="#B11-life-14-00575" rid="B11-life-14-00575" class=" bibr popnode">11</a>,<a href="#B22-life-14-00575" rid="B22-life-14-00575" class=" bibr popnode">22</a>,<a href="#B23-life-14-00575" rid="B23-life-14-00575" class=" bibr popnode">23</a>]. However, it should be noted that the medians of the majority of hematological and urine test parameters of the analyzed patients corresponded to reference values. Consequently, definite conclusions on chronic inflammation in convalescent HFRS cannot be drawn. Several of the analyzed post-HFRS patients also exhibited hematuria as a sign of glomerular damage, coinciding with the results of the study conducted by Sirotin et al. [<a href="#B21-life-14-00575" rid="B21-life-14-00575" class=" bibr popnode">21</a>]. The analyzed patients also had lower osmolality, agreeing with the findings of a similar study and implying urine concentration defects [<a href="#B28-life-14-00575" rid="B28-life-14-00575" class=" bibr popnode">28</a>]. Importantly, the patients analyzed in our study did not exhibit significantly lower levels of GFR when compared to the healthy control group. Considering that similar studies conducted three and six years after acute HFRS reported lower GFR levels, this finding could imply the eventual normalization of kidney function in later post-HFRS time points. Taken together, the results of the urine tests conducted in our study suggest milder levels of renal tubule damage as a possible consequence of hypertension and local inflammation 14 years after acute HFRS onset. </p><p>A significant part of our study consisted of analyzing additional ED markers in post-HFRS patients&#x02019; sera and urine. When considering acute HFRS, several studies demonstrated increased levels of several markers, including sICAM-1, sVCAM-1 and selectins [<a href="#B18-life-14-00575" rid="B18-life-14-00575" class=" bibr popnode">18</a>,<a href="#B19-life-14-00575" rid="B19-life-14-00575" class=" bibr popnode">19</a>]. However, ED markers in convalescent HFRS have not been analyzed, highlighting the importance of our study. While several serum ED markers, including P-selectin, E-selectin, sICAM-1 and VEGF, were increased in post-HFRS patients, these differences were not statistically significant when compared to healthy individuals. Similarly, urine sVCAM-1 values were on average fourfold higher in post-HFRS patients without reaching a statistically significant difference when compared to the control group, possibly due to data dispersion and a relatively small sample size. Consequently, concluding on the basis of these results should be carried out with caution. Furthermore, our logistic regression model demonstrated a weak association of serum levels of sVCAM-1 and urine levels of VEGF with HFRS contraction. Notably, this model achieved considerably high sensitivity and specificity in classifying post-HFRS patients and healthy individuals using only four predictors: CRP, urine microalbumin, serum sVCAM-1 and urine VEGF. Even though several ED marker levels were higher in post-HFRS patients than in healthy individuals, most of the stated differences were not significant and do not offer sufficient evidence for significant ED in HFRS patients 14 years after the disease contraction. However, future research on different HFRS patient cohorts should further explore the trends observed in this study and could provide more details on ED events at different time points after acute HFRS.</p><p class="p p-last">This study has several limitations. Firstly, the analyzed sample size was relatively small, resulting in lower power of the utilized statistical tests. The sample size was limited considering the status of HFRS as an epidemic disease with a relatively small incidence in Croatia and considering a relatively low response rate of post-HFRS patients 14 years after the disease onset. Another limitation is a lack of complete data on hematological, biochemical, urine and ED markers at earlier time points after HFRS contraction, which would allow for a detailed longitudinal analysis of HFRS sequelae. Additionally, the relatively low number of recruited post-HFRS patients infected with DOBV did not allow for comparisons of renal function and ED in post-HFRS patients infected with PUUV and DOBV. Furthermore, all of the patients included in this study were recruited from a single hospital center, limiting the persuasiveness of our findings. All in all, the results presented in this study point towards mild renal dysfunction in convalescent HFRS patients 14 years after the acute disease, possibly resulting from local inflammation, hypertension and renal ED. However, more research is needed to fully understand the role of ED in chronic HFRS sequelae.</p></div><div id="funding-group-a.i.b.w" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.i.b.wtitle">Funding Statement</h2><p>This work was supported by the grant 143-1430115-0103 from the Ministry of Science, Education and Sports of the Republic of Croatia.</p></div><div id="notes-a.k.b" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.btitle">Author Contributions</h2><p>Conceptualization, D.L., I.I. and A.M.; methodology, D.L., I.I. and A.T.; validation, J.W.L. and A.M.; formal analysis, K.B.; investigation, D.L., I.I. and A.T.; resources, D.L. and I.I.; data curation, D.L.; writing&#x02014;original draft preparation, K.B.; writing&#x02014;review and editing, D.L., I.I., A.T., J.W.L. and A.M.; supervision, I.I. and A.M.; project administration, D.L., I.I. and A.M.; funding acquisition, A.M. All authors have read and agreed to the published version of the manuscript.</p></div><div id="notes-a.k.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.ctitle">Institutional Review Board Statement</h2><p>The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee) of the School of Medicine, University of Zagreb (protocol code 251-59-10106-24-111/29 and date of approval 30 May 2008).</p></div><div id="notes-a.k.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.dtitle">Informed Consent Statement</h2><p>Informed consent was obtained from all subjects involved in the study.</p></div><div id="notes-a.k.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.etitle">Data Availability Statement</h2><p>The data presented in this study are available on request from the corresponding author.</p></div><div id="notes-a.k.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.k.ftitle">Conflicts of Interest</h2><p>The authors declare no conflicts of interest.</p></div><div id="fn-group-a.k.a" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.k.atitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.k.a.a"><p class="p p-first-last"><strong>Disclaimer/Publisher&#x02019;s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></p></div></div><div id="ref-list-a.k.g" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.k.gtitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1-life-14-00575">1. <span class="element-citation">Schmaljohn C., Hjelle B. Hantaviruses. A global disease problem. <span><span class="ref-journal">Emerg. Infect. Dis. </span>1997;<span class="ref-vol">3</span>:95–104. doi: 10.3201/eid0302.970202.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2627612/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9204290" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3201%2Feid0302.970202" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg.+Infect.+Dis.&amp;title=Hantaviruses.+A+global+disease+problem&amp;author=C.+Schmaljohn&amp;author=B.+Hjelle&amp;volume=3&amp;publication_year=1997&amp;pages=95-104&amp;pmid=9204290&amp;doi=10.3201/eid0302.970202&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2-life-14-00575">2. <span class="element-citation">Vaheri A., Henttonen H., Voutilanien L., Mustonen J., Sironem T., Vapalhti O. Hantavirus infections in Europe and their impact on public health. <span><span class="ref-journal">Rev. Med. Virol. </span>2013;<span class="ref-vol">23</span>:35–49. doi: 10.1002/rmv.1722.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22761056" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Frmv.1722" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev.+Med.+Virol.&amp;title=Hantavirus+infections+in+Europe+and+their+impact+on+public+health&amp;author=A.+Vaheri&amp;author=H.+Henttonen&amp;author=L.+Voutilanien&amp;author=J.+Mustonen&amp;author=T.+Sironem&amp;volume=23&amp;publication_year=2013&amp;pages=35-49&amp;pmid=22761056&amp;doi=10.1002/rmv.1722&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3-life-14-00575">3. <span class="element-citation">Huttunen N.P., M&#x000e4;kel&#x000e4; S., Pokka T., Mustonen J., Uhari M. Systematic literature review of symptoms, signs and severity of serologically confirmed nephropathia epidemica in paediatric and adult patients. <span><span class="ref-journal">Scand. J. Infect. Dis. </span>2011;<span class="ref-vol">43</span>:405–410. doi: 10.3109/00365548.2011.559666.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21341977" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3109%2F00365548.2011.559666" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand.+J.+Infect.+Dis.&amp;title=Systematic+literature+review+of+symptoms,+signs+and+severity+of+serologically+confirmed+nephropathia+epidemica+in+paediatric+and+adult+patients&amp;author=N.P.+Huttunen&amp;author=S.+M&#x000e4;kel&#x000e4;&amp;author=T.+Pokka&amp;author=J.+Mustonen&amp;author=M.+Uhari&amp;volume=43&amp;publication_year=2011&amp;pages=405-410&amp;pmid=21341977&amp;doi=10.3109/00365548.2011.559666&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4-life-14-00575">4. <span class="element-citation">Tur&#x0010d;inov D., Puljiz I., Markoti&#x00107; A., Kuzman I., Begovac J. Clinical and laboratory findings in patients with oliguric and non-oliguric Hantavirus haemorrhagic fever with renal syndrome: An analysis of 128 patients. <span><span class="ref-journal">Clin. Microbiol. Infect. </span>2013;<span class="ref-vol">19</span>:674–679. doi: 10.1111/j.1469-0691.2012.03994.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22963396" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1469-0691.2012.03994.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Microbiol.+Infect.&amp;title=Clinical+and+laboratory+findings+in+patients+with+oliguric+and+non-oliguric+Hantavirus+haemorrhagic+fever+with+renal+syndrome:+An+analysis+of+128+patients&amp;author=D.+Tur&#x0010d;inov&amp;author=I.+Puljiz&amp;author=A.+Markoti&#x00107;&amp;author=I.+Kuzman&amp;author=J.+Begovac&amp;volume=19&amp;publication_year=2013&amp;pages=674-679&amp;pmid=22963396&amp;doi=10.1111/j.1469-0691.2012.03994.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5-life-14-00575">5. <span class="element-citation">Mustonen J., Brummer-Korvenkontio M., Hedman K., Pasternack A., Pietil&#x000e4; K., Vaheri A. Nephropathia epidemica in Finland: A retrospective study of 126 cases. <span><span class="ref-journal">Scand. J. Infect. Dis. </span>1994;<span class="ref-vol">26</span>:7–13. doi: 10.3109/00365549409008583.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7910705" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3109%2F00365549409008583" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand.+J.+Infect.+Dis.&amp;title=Nephropathia+epidemica+in+Finland:+A+retrospective+study+of+126+cases&amp;author=J.+Mustonen&amp;author=M.+Brummer-Korvenkontio&amp;author=K.+Hedman&amp;author=A.+Pasternack&amp;author=K.+Pietil&#x000e4;&amp;volume=26&amp;publication_year=1994&amp;pages=7-13&amp;pmid=7910705&amp;doi=10.3109/00365549409008583&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6-life-14-00575">6. <span class="element-citation">Markoti&#x00107; A., Nichol S.T., Kuzman I., Sanchez A.J., Ksiazek T.G., Gagro A., Rabati&#x00107; S., Zgorelec R., Avsic-Zupanc T., Beus I., et al. Characteristics of Puumala and Dobrava infections in Croatia. <span><span class="ref-journal">J. Med. Virol. </span>2002;<span class="ref-vol">66</span>:542–551. doi: 10.1002/jmv.2179.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11857535" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjmv.2179" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Med.+Virol.&amp;title=Characteristics+of+Puumala+and+Dobrava+infections+in+Croatia&amp;author=A.+Markoti&#x00107;&amp;author=S.T.+Nichol&amp;author=I.+Kuzman&amp;author=A.J.+Sanchez&amp;author=T.G.+Ksiazek&amp;volume=66&amp;publication_year=2002&amp;pages=542-551&amp;pmid=11857535&amp;doi=10.1002/jmv.2179&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7-life-14-00575">7. <span class="element-citation">Hepojoki J., Vaheri A., Strandini A. The fundamental role of endothelial cells in hantavirus pathogenesis. <span><span class="ref-journal">Front. Microbiol. </span>2014;<span class="ref-vol">5</span>:727.  doi: 10.3389/fmicb.2014.00727.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4273638/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25566236" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffmicb.2014.00727" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Microbiol.&amp;title=The+fundamental+role+of+endothelial+cells+in+hantavirus+pathogenesis&amp;author=J.+Hepojoki&amp;author=A.+Vaheri&amp;author=A.+Strandini&amp;volume=5&amp;publication_year=2014&amp;pages=727&amp;pmid=25566236&amp;doi=10.3389/fmicb.2014.00727&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8-life-14-00575">8. <span class="element-citation">Geimonen E., Neff S., Raymond T., Kocek S.S., Gavrilovskaya I.N., Mackow E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>2002;<span class="ref-vol">99</span>:13837–13842. doi: 10.1073/pnas.192298899.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC129784/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12368479" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.192298899" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Pathogenic+and+nonpathogenic+hantaviruses+differentially+regulate+endothelial+cell+responses&amp;author=E.+Geimonen&amp;author=S.+Neff&amp;author=T.+Raymond&amp;author=S.S.+Kocek&amp;author=I.N.+Gavrilovskaya&amp;volume=99&amp;publication_year=2002&amp;pages=13837-13842&amp;pmid=12368479&amp;doi=10.1073/pnas.192298899&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9-life-14-00575">9. <span class="element-citation">Jiang H., Du H., Wang L.M., Wang P.Z., Bai X.F. Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture. <span><span class="ref-journal">Front. Cell. Infect. Microbiol. </span>2016;<span class="ref-vol">6</span>:1.  doi: 10.3389/fcimb.2016.00001.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4737898/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26870699" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffcimb.2016.00001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Cell.+Infect.+Microbiol.&amp;title=Hemorrhagic+Fever+with+Renal+Syndrome:+Pathogenesis+and+Clinical+Picture&amp;author=H.+Jiang&amp;author=H.+Du&amp;author=L.M.+Wang&amp;author=P.Z.+Wang&amp;author=X.F.+Bai&amp;volume=6&amp;publication_year=2016&amp;pages=1&amp;pmid=26870699&amp;doi=10.3389/fcimb.2016.00001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10-life-14-00575">10. <span class="element-citation">Mir S. Hantavirus Induced Kidney Disease. <span><span class="ref-journal">Front. Med. </span>2021;<span class="ref-vol">8</span>:795340. doi: 10.3389/fmed.2021.795340.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8804099/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35118091" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffmed.2021.795340" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Med.&amp;title=Hantavirus+Induced+Kidney+Disease&amp;author=S.+Mir&amp;volume=8&amp;publication_year=2021&amp;pages=795340&amp;doi=10.3389/fmed.2021.795340&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11-life-14-00575">11. <span class="element-citation">Tulumovi&#x00107; D., Imamovi&#x00107; G., Mesi&#x00107; E., Huki&#x00107; M., Tulumovi&#x00107; A., Imamovi&#x00107; A., Zerem E. Comparison of the effect of Puumala and Dobrava viruses on early and long&#x02013;term renal outcomes in patients with haemorrhagic fever with renal syndrome. <span><span class="ref-journal">Nephrol. </span>2010;<span class="ref-vol">15</span>:340–343. doi: 10.1111/j.1440-1797.2009.01195.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20470304" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1440-1797.2009.01195.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol&amp;title=Comparison+of+the+effect+of+Puumala+and+Dobrava+viruses+on+early+and+long&#x02013;term+renal+outcomes+in+patients+with+haemorrhagic+fever+with+renal+syndrome&amp;author=D.+Tulumovi&#x00107;&amp;author=G.+Imamovi&#x00107;&amp;author=E.+Mesi&#x00107;&amp;author=M.+Huki&#x00107;&amp;author=A.+Tulumovi&#x00107;&amp;volume=15&amp;publication_year=2010&amp;pages=340-343&amp;pmid=20470304&amp;doi=10.1111/j.1440-1797.2009.01195.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12-life-14-00575">12. <span class="element-citation">Alla-Houhala I., Koskinen M., Ahola T., Harmoinen A., Kouri T., Laurila K., Mustonen J., Pasternack A. Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus. <span><span class="ref-journal">Nephrol. Dial. Transplant. </span>2002;<span class="ref-vol">17</span>:246–252. doi: 10.1093/ndt/17.2.246.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11812874" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fndt%2F17.2.246" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol.+Dial.+Transplant.&amp;title=Increased+glomerular+permeability+in+patients+with+nephropathia+epidemica+caused+by+Puumala+hantavirus&amp;author=I.+Alla-Houhala&amp;author=M.+Koskinen&amp;author=T.+Ahola&amp;author=A.+Harmoinen&amp;author=T.+Kouri&amp;volume=17&amp;publication_year=2002&amp;pages=246-252&amp;pmid=11812874&amp;doi=10.1093/ndt/17.2.246&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13-life-14-00575">13. <span class="element-citation">Cvetko Krajinovi&#x00107; L., Boduli&#x00107; K., La&#x00161;kaj R., &#x0017d;ibrat B., Svoboda Kari&#x00107; P., Kurolt I.C., Kordun M., Topi&#x00107; A., &#x0010c;ivljak R., Skuhala T., et al. Hemorrhagic Fever with Renal Syndrome Patients Exhibit Increased Levels of Lipocalin-2, Endothelin-1 and NT-proBNP. <span><span class="ref-journal">Life. </span>2023;<span class="ref-vol">13</span>:2189.  doi: 10.3390/life13112189.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10672301/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38004329" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Flife13112189" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Life&amp;title=Hemorrhagic+Fever+with+Renal+Syndrome+Patients+Exhibit+Increased+Levels+of+Lipocalin-2,+Endothelin-1+and+NT-proBNP&amp;author=L.+Cvetko+Krajinovi&#x00107;&amp;author=K.+Boduli&#x00107;&amp;author=R.+La&#x00161;kaj&amp;author=B.+&#x0017d;ibrat&amp;author=P.+Svoboda+Kari&#x00107;&amp;volume=13&amp;publication_year=2023&amp;pages=2189&amp;pmid=38004329&amp;doi=10.3390/life13112189&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14-life-14-00575">14. <span class="element-citation">Vaccaro F., Picone F.P., Montalto G., Cerasola G. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein. <span><span class="ref-journal">Arch. Med. Res. </span>2007;<span class="ref-vol">38</span>:534–538. doi: 10.1016/j.arcmed.2007.01.013.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17560459" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.arcmed.2007.01.013" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Med.+Res.&amp;title=Circulating+levels+of+adhesion+molecules+in+chronic+kidney+disease+correlate+with+the+stage+of+renal+disease+and+with+C-reactive+protein&amp;author=F.+Vaccaro&amp;author=F.P.+Picone&amp;author=G.+Montalto&amp;author=G.+Cerasola&amp;volume=38&amp;publication_year=2007&amp;pages=534-538&amp;pmid=17560459&amp;doi=10.1016/j.arcmed.2007.01.013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15-life-14-00575">15. <span class="element-citation">Jacobson S.H., Egberg N., Hylander B., Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. <span><span class="ref-journal">Am. J. Nephrol. </span>2002;<span class="ref-vol">22</span>:42–47. doi: 10.1159/000046673.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11919402" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1159%2F000046673" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Nephrol.&amp;title=Correlation+between+soluble+markers+of+endothelial+dysfunction+in+patients+with+renal+failure&amp;author=S.H.+Jacobson&amp;author=N.+Egberg&amp;author=B.+Hylander&amp;author=J.+Lundahl&amp;volume=22&amp;publication_year=2002&amp;pages=42-47&amp;pmid=11919402&amp;doi=10.1159/000046673&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16-life-14-00575">16. <span class="element-citation">Stam F., van Guldener C., Becker A., Deker J.M., Heine R.J., Boter L.M., Stehouwer C.D.A. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn study. <span><span class="ref-journal">J. Am. Soc. Nephrol. </span>2006;<span class="ref-vol">17</span>:537–545. doi: 10.1681/ASN.2005080834.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16382015" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1681%2FASN.2005080834" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Soc.+Nephrol.&amp;title=Endothelial+dysfunction+contributes+to+renal+function-associated+cardiovascular+mortality+in+a+population+with+mild+renal+insufficiency:+The+Hoorn+study&amp;author=F.+Stam&amp;author=C.+van+Guldener&amp;author=A.+Becker&amp;author=J.M.+Deker&amp;author=R.J.+Heine&amp;volume=17&amp;publication_year=2006&amp;pages=537-545&amp;pmid=16382015&amp;doi=10.1681/ASN.2005080834&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17-life-14-00575">17. <span class="element-citation">Pal E., Korva M., Resman Rus K., Kej&#x0017e;ar N., Bogovi&#x00107; P., Strle F., Av&#x00161;i&#x00107;-&#x0017d;upanc T. Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome. <span><span class="ref-journal">Emerg. Microb. Infect. </span>2018;<span class="ref-vol">16</span>:89. doi: 10.1038/s41426-018-0090-5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5953927/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29765019" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41426-018-0090-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg.+Microb.+Infect.&amp;title=Relationship+between+circulating+vascular+endothelial+growth+factor+and+its+soluble+receptor+in+patients+with+hemorrhagic+fever+with+renal+syndrome&amp;author=E.+Pal&amp;author=M.+Korva&amp;author=K.+Resman+Rus&amp;author=N.+Kej&#x0017e;ar&amp;author=P.+Bogovi&#x00107;&amp;volume=16&amp;publication_year=2018&amp;pages=89&amp;pmid=29765019&amp;doi=10.1038/s41426-018-0090-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18-life-14-00575">18. <span class="element-citation">Bellomo C., Korva M., Papa A., M&#x000e4;kel&#x000e4; S., Mustonen J., Av&#x00161;i&#x00107;-&#x0017d;upanc T., Vaheri A., Martinez V.P., Strandin T. Differential Regulation of PAI-1 in Hantavirus Cardiopulmonary Syndrome and Hemorrhagic Fever With Renal Syndrome. <span><span class="ref-journal">Open. Forum. Infect. Dis. </span>2018;<span class="ref-vol">2</span>:ofy021. doi: 10.1093/ofid/ofy021.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5808793/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29450213" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fofid%2Fofy021" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Open.+Forum.+Infect.+Dis.&amp;title=Differential+Regulation+of+PAI-1+in+Hantavirus+Cardiopulmonary+Syndrome+and+Hemorrhagic+Fever+With+Renal+Syndrome&amp;author=C.+Bellomo&amp;author=M.+Korva&amp;author=A.+Papa&amp;author=S.+M&#x000e4;kel&#x000e4;&amp;author=J.+Mustonen&amp;volume=2&amp;publication_year=2018&amp;pages=ofy021&amp;pmid=29450213&amp;doi=10.1093/ofid/ofy021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19-life-14-00575">19. <span class="element-citation">Qi B.T., Wang P., Li J., Ren H.X., Xie M. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-2 in plasma of patients with hemorrhagic fever with renal syndrome, and significance of the changes in level. <span><span class="ref-journal">Viral. Immunol. </span>2006;<span class="ref-vol">19</span>:565–569. doi: 10.1089/vim.2006.19.565.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16987074" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1089%2Fvim.2006.19.565" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Viral.+Immunol.&amp;title=Levels+of+soluble+vascular+cell+adhesion+molecule-1+and+soluble+intercellular+adhesion+molecule-2+in+plasma+of+patients+with+hemorrhagic+fever+with+renal+syndrome,+and+significance+of+the+changes+in+level&amp;author=B.T.+Qi&amp;author=P.+Wang&amp;author=J.+Li&amp;author=H.X.+Ren&amp;author=M.+Xie&amp;volume=19&amp;publication_year=2006&amp;pages=565-569&amp;pmid=16987074&amp;doi=10.1089/vim.2006.19.565&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20-life-14-00575">20. <span class="element-citation">Takala A., L&#x000e4;hdevirta J., Jansson S.E., Vapalahti O., Orpana A., Karonen S.L., Repo H. Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. <span><span class="ref-journal">J. Infect. Dis. </span>2000;<span class="ref-vol">181</span>:1964–1970. doi: 10.1086/315522.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10837176" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1086%2F315522" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Infect.+Dis.&amp;title=Systemic+inflammation+in+hemorrhagic+fever+with+renal+syndrome+correlates+with+hypotension+and+thrombocytopenia+but+not+with+renal+injury&amp;author=A.+Takala&amp;author=J.+L&#x000e4;hdevirta&amp;author=S.E.+Jansson&amp;author=O.+Vapalahti&amp;author=A.+Orpana&amp;volume=181&amp;publication_year=2000&amp;pages=1964-1970&amp;pmid=10837176&amp;doi=10.1086/315522&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21-life-14-00575">21. <span class="element-citation">Sirotin B.Z., Shapiro I.A., Menshin V.N. Tubulointerstitial changes in patients with a history of hemorrhagic fever with renal syndrome. <span><span class="ref-journal">Ter. Arkh. </span>1989;<span class="ref-vol">61</span>:51–59.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2576473" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ter.+Arkh.&amp;title=Tubulointerstitial+changes+in+patients+with+a+history+of+hemorrhagic+fever+with+renal+syndrome&amp;author=B.Z.+Sirotin&amp;author=I.A.+Shapiro&amp;author=V.N.+Menshin&amp;volume=61&amp;publication_year=1989&amp;pages=51-59&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22-life-14-00575">22. <span class="element-citation">Miettinen M.H., M&#x000e4;kel&#x000e4; S.M., Ala-Houhala I.O., Huhtala H.S., K&#x000f6;&#x000f6;bi T., Vaheri A.I., Pasternack A.I., Mustonen J.T. Tubular proteinuia and glomerual filtration 6 years after puumala hantavirus-induced acute interstitial nephritis. Nephron. <span><span class="ref-journal">Clin. Pract. </span>2009;<span class="ref-vol">112</span>:115–120.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19390211" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Pract.&amp;title=Tubular+proteinuia+and+glomerual+filtration+6+years+after+puumala+hantavirus-induced+acute+interstitial+nephritis.+Nephron&amp;author=M.H.+Miettinen&amp;author=S.M.+M&#x000e4;kel&#x000e4;&amp;author=I.O.+Ala-Houhala&amp;author=H.S.+Huhtala&amp;author=T.+K&#x000f6;&#x000f6;bi&amp;volume=112&amp;publication_year=2009&amp;pages=115-120&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23-life-14-00575">23. <span class="element-citation">Ledina D., Bradari&#x00107; N., Ivi&#x00107; I., Marasovi&#x00107; D., Radovi&#x00107; D., Ostoji&#x00107;-Bakotin V., Prgomet S. Is permanent renal function damage possible after hemorrhagic fever with renal syndrome? <span><span class="ref-journal">Acta. Med. Croatica. </span>2003;<span class="ref-vol">57</span>:365–368.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15011462" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta.+Med.+Croatica.&amp;title=Is+permanent+renal+function+damage+possible+after+hemorrhagic+fever+with+renal+syndrome?&amp;author=D.+Ledina&amp;author=N.+Bradari&#x00107;&amp;author=I.+Ivi&#x00107;&amp;author=D.+Marasovi&#x00107;&amp;author=D.+Radovi&#x00107;&amp;volume=57&amp;publication_year=2003&amp;pages=365-368&amp;pmid=15011462&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24-life-14-00575">24. <span class="element-citation">Dudarev M.V., Pimenov L.T. Long-term outcomes and formation of chronic disease of the kidneys in patients with a history of hemorrhagic fever with renal syndrome. <span><span class="ref-journal">Ter. Arkh. </span>2008;<span class="ref-vol">80</span>:59–62.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18655478" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ter.+Arkh.&amp;title=Long-term+outcomes+and+formation+of+chronic+disease+of+the+kidneys+in+patients+with+a+history+of+hemorrhagic+fever+with+renal+syndrome&amp;author=M.V.+Dudarev&amp;author=L.T.+Pimenov&amp;volume=80&amp;publication_year=2008&amp;pages=59-62&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25-life-14-00575">25. <span class="element-citation">R Core Team  . <span class="ref-journal">R: A Language and Environment for Statistical Computing.</span> R Foundation for Statistical Computing; Vienna, Austria: 2024.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=R:+A+Language+and+Environment+for+Statistical+Computing&amp;publication_year=2024&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26-life-14-00575">26. <span class="element-citation">Puljiz I., Kuzman I., Turcinov D., Makek N., Markoti&#x00107; A. Laboratory findings in patients with hemorrhagic fever with renal syndrome. <span><span class="ref-journal">Acta. Med. Croatica. </span>2005;<span class="ref-vol">59</span>:105–111.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15909883" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta.+Med.+Croatica.&amp;title=Laboratory+findings+in+patients+with+hemorrhagic+fever+with+renal+syndrome&amp;author=I.+Puljiz&amp;author=I.+Kuzman&amp;author=D.+Turcinov&amp;author=N.+Makek&amp;author=A.+Markoti&#x00107;&amp;volume=59&amp;publication_year=2005&amp;pages=105-111&amp;pmid=15909883&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27-life-14-00575">27. <span class="element-citation">Taqir M., Kim D.M. Hemorrhagic Fever with Renal Syndrome: Literature Review, Epidemiology, Clinical Picture and Pathogenesis. <span><span class="ref-journal">Infect. Chemoter. </span>2022;<span class="ref-vol">54</span>:1–19.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8987181/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35384417" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect.+Chemoter.&amp;title=Hemorrhagic+Fever+with+Renal+Syndrome:+Literature+Review,+Epidemiology,+Clinical+Picture+and+Pathogenesis&amp;author=M.+Taqir&amp;author=D.M.+Kim&amp;volume=54&amp;publication_year=2022&amp;pages=1-19&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28-life-14-00575">28. <span class="element-citation">Tarvainen M., M&#x000e4;kel&#x000e4; S., Laine O., P&#x000f6;rsti I., Risku S., Niemel&#x000e4; O., Mustonen J., Jaatinen P. Hormonal Defects Are Common during Puumala Hantavirus Infection and Associate with Disease Severity and Biomarkers of Altered Haemostasis. <span><span class="ref-journal">Viruses. </span>2021;<span class="ref-vol">13</span>:1818.  doi: 10.3390/v13091818.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8472102/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34578397" ref="reftype=pubmed&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fv13091818" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Viruses&amp;title=Hormonal+Defects+Are+Common+during+Puumala+Hantavirus+Infection+and+Associate+with+Disease+Severity+and+Biomarkers+of+Altered+Haemostasis&amp;author=M.+Tarvainen&amp;author=S.+M&#x000e4;kel&#x000e4;&amp;author=O.+Laine&amp;author=I.+P&#x000f6;rsti&amp;author=S.+Risku&amp;volume=13&amp;publication_year=2021&amp;pages=1818&amp;pmid=34578397&amp;doi=10.3390/v13091818&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11122023&amp;issue-id=463253&amp;journal-id=2582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Life</span> are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11122023/pdf/life-14-00575.pdf" class="int-view">PDF (222K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11122023/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11122023/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11122023" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11122023%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="XoXTVVCKyT49IAOdNBBpbyD1rc8kaL4kEx1F2v13UlQMRjAnkuQOiCPSPewEOfyn">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11122023%2F&amp;text=A%20Comprehensive%20Analysis%20of%20Renal%20and%20Endothelium%20Dysfunction%20Markers%20Fourteen%20Years%20after%20Hemorrhagic%20Fever%20with%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11122023%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11122023/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11122023/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38792596/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11122023/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38792596/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11122023/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11122023/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC11122023/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
